Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Fuji
Moodys
Healthtrust
Deloitte
Novartis
Boehringer Ingelheim
US Department of Justice
Accenture

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012157

« Back to Dashboard

NDA 012157 describes NORFLEX, which is a drug marketed by Teligent and Medicis and is included in two NDAs. Additional details are available on the NORFLEX profile page.

The generic ingredient in NORFLEX is orphenadrine citrate. There are nine drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the orphenadrine citrate profile page.
Summary for 012157
Tradename:NORFLEX
Applicant:Medicis
Ingredient:orphenadrine citrate
Patents:0
Therapeutic Class:Skeletal Muscle Relaxants
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Covington
Medtronic
Moodys
Daiichi Sankyo
Boehringer Ingelheim
Deloitte
Julphar
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot